You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial

Citation Tools

Article menu

Download PDFPDF

XML
Clinical care/Education/Nutrition
Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Perez A, Carrasco-Sánchez FJ, González C, et al
Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial
BMJ Open Diabetes Research and Care 2020;8:e001518. doi: 10.1136/bmjdrc-2020-001518